Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Nitration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN107286043A details a low-pollution catalytic route for high-purity dye and pharma intermediates, offering significant cost reduction and supply chain reliability.
Discover the patented CN103804221A method for 4-(4-aminophenyl)-3-morpholone. Achieve high purity without palladium catalysts for cost-effective Razaxaban intermediate manufacturing.
Patent CN1222523A details a novel route for 9-amino camptothecin, recycling 12-nitro byproducts to ensure cost reduction in pharmaceutical manufacturing and high purity.
Patent CN110407846A reveals high-purity 5-ISMN synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Discover CN1268601C technology for synthesizing 5-nitrobenzofuran derivatives. Enhanced regioselectivity, scalable nitration processes, and cost-effective pharmaceutical intermediate manufacturing solutions.
Novel route for 2-hydroxy-4-amino-5-methylpyridine via N-oxide activation. Offers high yield, low cost, and scalable manufacturing for global pharma supply chains.
Patent CN1809525A enables sulfuric-free nitration for 3-nitro-4-alkoxybenzoic acid. Achieve high purity and reduced waste for reliable dye and pharma intermediate supply chains.
Patent CN101948389A reveals a high-yield route for Flumioxazin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for this critical agrochemical building block.
Patent CN103880740A reveals a high-selectivity synthesis route for 4-nitro-3-hydroxy-2-picolinic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110540522B reveals a mild nitration method for pyridine amines. Discover cost-effective, scalable synthesis for energetic material intermediates.
Patent CN101955443B reveals a novel route for tigecycline intermediates, bypassing minocycline to reduce costs and improve purity for reliable pharmaceutical intermediate suppliers.
Patent CN1379754A reveals a novel selective nitration route for 5-nitrobenzofuran intermediates, offering cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN112679365A reveals a scalable 4-step synthesis for 6-bromonaphthalene-1,2-diamine, a key HCV inhibitor intermediate, offering cost-effective manufacturing solutions.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN103288757A reveals a novel solid-acid catalyzed nitration route for key TKI intermediates, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Novel room temperature nitration process enhances purity and yield. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN112125805A reveals a novel selective nitration process for magnolol derivatives, eliminating column chromatography and enabling scalable, cost-effective production of high-purity intermediates.